Celldex Therapeutics, Inc.· CLDX

🇺🇸 US · MidBroad USNASDAQ

HealthcareBiotechnologyWebsite

Price: $39.05
Day: +3.61%
Mkt Cap: $2.60B
52W Range: $19.72 – $40.30
Volume: 1.02M
Beta: 0.90

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Blog

stockoscope.com

Celldex Therapeutics, Inc.

CLDX|Healthcare|Biotechnology

Comparing against 140 sector peers in United States · Mid Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

0%ile

-89.1%

Operating Margin

N/A

ROIC

4%ile

-67.0%

FCF Yield

9%ile

-8.7%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

59.7%

EBIT Growth

58.6%

Net Income Growth

58.6%

OCF Growth

29.5%

FCF Growth

31.2%

Income Quality

0.78

Returns on Capital (TTM)

ROE(-50.7%)

12%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-67.2%)

4%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROA(-55.5%)

5%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(-67.0%)

4%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

EBITDA Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Operating Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Net Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

90%ile

0.00

Debt/Capital

90%ile

0.00

Net Debt/EBITDA

91%ile

0.12

Interest Coverage

N/A

Liquidity (TTM)

Current Ratio

68%ile

8.92

Quick Ratio

70%ile

8.92

Cash Ratio

28%ile

0.69

WC Turnover

24%ile

0.00

Operational Efficiency (TTM)

Asset Turnover

1%ile

0.00

DSO

8%ile

102

Days Inventory

74%ile

0.00

Cash Conv. Cycle

40%ile

70.3

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore CLDX on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

140 sector peers (United States · Mid Cap · Healthcare)

Relative Quality

CLDX Relative Quality Score

Ranked against 140 sector peers in United States · Mid Cap · Healthcare

Relative Quality

2.7/5

Adequate

vs 140 sector peers

Peer Rankings (7 of 10 available)

Relative Quality Score of 2.74/5 (Adequate) based on percentile rankings against 140 sector peers in United States · Mid Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated August 5, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

0th percentile, Poor

Value: -89.15%
Percentile: 0%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm revenue growth of -89.15% and ranks at the 0th percentile vs United States · Healthcare sector peers. Poor financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

No data for Gross Margin is available for CLDX, so peer comparison is hidden for this metric. Try another metric.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

1st percentile, Poor

Value: 0.00
Percentile: 1%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm asset turnover of 0.00 and ranks at the 1st percentile vs United States · Healthcare sector peers. Poor financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

5th percentile, Poor

Value: -55.49%
Percentile: 5%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm roa of -55.49% and ranks at the 5th percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

63rd percentile, Strong

Value: 29.53%
Percentile: 63%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm operating cash flow growth of 29.53% and ranks at the 63rd percentile vs United States · Healthcare sector peers. Strong financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

28th percentile, Weak

Value: 0.69
Percentile: 28%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm cash ratio of 0.69 and ranks at the 28th percentile vs United States · Healthcare sector peers. Below average financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

90th percentile, Exceptional

Value: 0.00
Percentile: 90%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

CLDX has a ttm debt-to-capital of 0.00 and ranks at the 90th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -9.15
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank CLDX for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for CLDX, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 140 companies CLDX is compared against across its sector and industry cohorts.

Celldex Therapeutics, Inc.· CLDX

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies